Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

CERS vs OFIX: stock comparison and AI forecast

Cerus Corp (CERS) and Orthofix Medical Inc. (OFIX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Surgical & Medical Instruments & Apparatus

CERS Cerus Corp

Market Cap
$429M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Surgical & Medical Instruments & Apparatus

OFIX Orthofix Medical Inc.

Market Cap
$363M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

CERS · OFIX

Key facts

  • CERS is 1.2 times larger than OFIX by market capitalization ($429M against $363M).
  • CERS carries 1.70 times debt per unit of equity, against 1.03 times for OFIX.
  • Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricCERSOFIX
Market Cap$429M$363M
P/B Ratio5.67x0.85x
EPS$-0.08$-1.01
Book Value/Share$0.38$10.54
Revenue/Share$2.00$20.46
FCF/Share$0.00$-0.68

Profitability & Margins

MetricCERSOFIX
ROIC-2.0%-5.5%
Gross Margin–71.3%
Operating Margin-0.6%-4.7%
EBT Margin-1.7%-7.2%
Tax Rate-5.3%-2.4%

Financial Health

MetricCERSOFIX
Current Ratio1.96x2.84x
Quick Ratio1.15x1.67x
D/E Ratio1.70x1.03x
Financial Leverage2.70x2.03x
Interest Coverage-0.1x1.3x
Working Capital$77M$289M

Cash Flow

MetricCERSOFIX
Operating Cash Flow$4M$16M
Free Cash Flow$490K-$28M
Capital Spending-$3M-$44M
OCF Growth YoY-1.9%-43.2%
FCF Growth YoY194.1%–
FCF/Sales0.1%-3.3%
CapEx/Sales0.8%5.3%

Operational Efficiency

MetricCERSOFIX
Asset Turnover1.97x0.95x
Receivables Turnover13.2x6.1x
Inventory Turnover–1.3x
Fixed Assets Turnover42.7x6.4x
Days Sales Outstanding28 days60 days
Days Inventory–282 days
Payables Period–97 days
Cash Conversion Cycle–244 days

Income Statement

MetricCERSOFIX
Total Revenue$403M$833M
Operating Income-$2M-$39M
R&D Expense$60M$61M
SG&A Expense$86M$558M
Cost of Goods Sold–$239M

Dividend & Shareholder Information

MetricCERSOFIX
Shares Outstanding202M41M
FAQ

CERS vs OFIX: stock comparison and AI forecast

Which is bigger, CERS or OFIX?

CERS is 1.2 times larger than OFIX by market capitalization ($429M against $363M).

Which one does Intratio's AI model rank higher, CERS or OFIX?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.